CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

9478	Companies
185489	Keywords
117869	Articles
99348	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 09/22/2025 at 07:30, 2 months 13 days ago

CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
CROSSJECT secures $11.3 million BARDA funding for ZEPIZURE® development towards FDA authorization. Advances include validation batches and facility audit completion

BARDA Funding Crossject FDA Authorization ZEPIZURE Development Emergency Auto-injectors
PRESS RELEASE

published on 09/22/2025 at 07:30, 2 months 13 days ago

CROSSJECT obtient un financement supplémentaire de la BARDA pour soutenir le développement et l'autorisation par la FDA de ZEPIZURE®
CROSSJECT obtient un financement supplémentaire de 11,3 millions de dollars de la BARDA pour le développement de ZEPIZURE® approuvé par la FDA

FDA Financement Crossject ZEPIZURE BARDA
BRIEF

published on 07/01/2025 at 07:35, 5 months 4 days ago

Change of liquidity contract for CROSSJECT

Liquidity Euronext Pharmaceutical Contract Crossject
BRIEF

published on 07/01/2025 at 07:35, 5 months 4 days ago

Changement de contrat de liquidité pour CROSSJECT

Contrat Euronext Liquidité Pharmaceutique Crossject
PRESS RELEASE

published on 07/01/2025 at 07:30, 5 months 4 days ago

CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité
CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité avec Rothschild Martin Maurel pour favoriser la liquidité des transactions. Détails du contrat et impacts sur le marché réglementé d'Euronext

Contrat De Liquidité Rothschild Martin Maurel Euronext Crossject ZENEO®
BRIEF

published on 06/24/2025 at 19:05, 5 months 10 days ago

CROSSJECT obtient une augmentation de capital de 5,7 millions d'euros

Augmentation De Capital Soumission À La FDA ZEPIZURE® Gemmes Venture Vatel Capital
BRIEF

published on 06/24/2025 at 19:05, 5 months 10 days ago

CROSSJECT Secures €5.7 Million in Capital Increase

Capital Increase FDA Submission ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 5 months 10 days ago

CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause
CROSSJECT successfully completes a capital increase of €5.7 million through preferential subscription rights, benefiting from new investor support and Gemmes Venture, to advance ZEPIZURE® development

Capital Increase Crossject ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 5 months 10 days ago

CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension
CROSSJECT annonce le vif succès de son augmentation de capital à 5,7 millions d’euros après exercice intégral de la clause d’extension pour ZEPIZURE®

Financement Augmentation De Capital Pharmaceutique Crossject ZEPIZURE
BRIEF

published on 06/11/2025 at 07:35, 5 months 24 days ago

CROSSJECT advances in the development of ZEPIZURE® Junior for children

Epilepsy Pediatrics Crossject Auto-injector ZEPIZURE Junior

Accesswire

Published on 12/05/2025 at 16:00, 21 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 36 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 36 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 46 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 56 minutes ago

Usha Resources Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:10, 11 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 21 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 21 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 21 minutes ago

Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 21 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 10 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 10 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 22 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 36 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 36 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE